<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="nl">
	<id>https://zibs.test-nictiz.nl/index.php?action=history&amp;feed=atom&amp;title=DrugsGebruik-v3.5%282026-1NL%29</id>
	<title>DrugsGebruik-v3.5(2026-1NL) - Bewerkingsoverzicht</title>
	<link rel="self" type="application/atom+xml" href="https://zibs.test-nictiz.nl/index.php?action=history&amp;feed=atom&amp;title=DrugsGebruik-v3.5%282026-1NL%29"/>
	<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=DrugsGebruik-v3.5(2026-1NL)&amp;action=history"/>
	<updated>2026-04-17T16:58:28Z</updated>
	<subtitle>Bewerkingsoverzicht voor deze pagina op de wiki</subtitle>
	<generator>MediaWiki 1.43.0</generator>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=DrugsGebruik-v3.5(2026-1NL)&amp;diff=33954&amp;oldid=prev</id>
		<title>Update bot op 17 apr 2026 om 10:23</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=DrugsGebruik-v3.5(2026-1NL)&amp;diff=33954&amp;oldid=prev"/>
		<updated>2026-04-17T10:23:36Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;nl&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Oudere versie&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Versie van 17 apr 2026 12:23&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l5&quot;&gt;Regel 5:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Regel 5:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Naam&amp;lt;!--hdName--&amp;gt;: &amp;#039;&amp;#039;&amp;#039;nl.zorg.DrugsGebruik&amp;#039;&amp;#039;&amp;#039; [[Bestand:EN.png|link=DrugUse-v3.5(2026-1EN)]]&amp;lt;BR&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Naam&amp;lt;!--hdName--&amp;gt;: &amp;#039;&amp;#039;&amp;#039;nl.zorg.DrugsGebruik&amp;#039;&amp;#039;&amp;#039; [[Bestand:EN.png|link=DrugUse-v3.5(2026-1EN)]]&amp;lt;BR&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Versie&amp;lt;!--hdVersion--&amp;gt;: &amp;#039;&amp;#039;&amp;#039;3.5&amp;#039;&amp;#039;&amp;#039; &amp;lt;br&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Versie&amp;lt;!--hdVersion--&amp;gt;: &amp;#039;&amp;#039;&amp;#039;3.5&amp;#039;&amp;#039;&amp;#039; &amp;lt;br&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;ZIB Status&amp;lt;!--hdStatus--&amp;gt;:&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Draft&lt;/del&gt;&amp;lt;br&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;ZIB Status&amp;lt;!--hdStatus--&amp;gt;:&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Final&lt;/ins&gt;&amp;lt;br&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Publicatie&amp;lt;!--hdPublication--&amp;gt;: &amp;#039;&amp;#039;&amp;#039;2026-1&amp;#039;&amp;#039;&amp;#039; &amp;lt;br&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Publicatie&amp;lt;!--hdPublication--&amp;gt;: &amp;#039;&amp;#039;&amp;#039;2026-1&amp;#039;&amp;#039;&amp;#039; &amp;lt;br&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Publicatie status&amp;lt;!--hdPublicationStatus--&amp;gt;: &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Unpublished&lt;/del&gt;&amp;lt;br&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Publicatie status&amp;lt;!--hdPublicationStatus--&amp;gt;: &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Prepublished&lt;/ins&gt;&amp;lt;br&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Publicatie datum&amp;lt;!--hdPublicationDate--&amp;gt;:  &lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Publicatie datum&amp;lt;!--hdPublicationDate--&amp;gt;: &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;17-04-2026&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;!-- Aanroep Errata transclude page --&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;!-- Aanroep Errata transclude page --&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{Errata&amp;lt;!--hdErrata--&amp;gt;|2026-1|{{PAGENAME}}}}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{Errata&amp;lt;!--hdErrata--&amp;gt;|2026-1|{{PAGENAME}}}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l44&quot;&gt;Regel 44:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Regel 44:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|style=&amp;quot;width:250px; &amp;quot;|DCM::KeywordList||drugsgebruik, verdovende middelen, middelen gebruik, drugs&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|style=&amp;quot;width:250px; &amp;quot;|DCM::KeywordList||drugsgebruik, verdovende middelen, middelen gebruik, drugs&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|-  &lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|-  &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|style=&quot;width:250px; &quot;|DCM::LifecycleStatus||&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Draft&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|style=&quot;width:250px; &quot;|DCM::LifecycleStatus||&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Final&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|-  &lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|-  &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|style=&amp;quot;width:250px; &amp;quot;|DCM::ModelerList||Kerngroep Registratie aan de Bron&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|style=&amp;quot;width:250px; &amp;quot;|DCM::ModelerList||Kerngroep Registratie aan de Bron&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l50&quot;&gt;Regel 50:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Regel 50:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|style=&amp;quot;width:250px; &amp;quot;|DCM::Name||nl.zorg.DrugsGebruik&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|style=&amp;quot;width:250px; &amp;quot;|DCM::Name||nl.zorg.DrugsGebruik&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|-  &lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|-  &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|style=&quot;width:250px; &quot;|DCM::PublicationDate||&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|style=&quot;width:250px; &quot;|DCM::PublicationDate||&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;17-04-2026&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|-  &lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|-  &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|style=&quot;width:250px; &quot;|DCM::PublicationStatus||&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Unpublished&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|style=&quot;width:250px; &quot;|DCM::PublicationStatus||&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Prepublished&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|-  &lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|-  &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|style=&amp;quot;width:250px; &amp;quot;|DCM::ReviewerList||Projectgroep Generieke Overdrachtsgegevens &amp;amp; Kerngroep Registratie aan de Bron&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|style=&amp;quot;width:250px; &amp;quot;|DCM::ReviewerList||Projectgroep Generieke Overdrachtsgegevens &amp;amp; Kerngroep Registratie aan de Bron&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l685&quot;&gt;Regel 685:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Regel 685:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;/ul&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;/ul&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;De voorwaarden van gebruik staan op de beginpagina&amp;lt;!--ftConditions--&amp;gt; [[Bestand:list2.png|link=ZIB_Hoofdpagina&amp;lt;!--wikiMainpage--&amp;gt;]]&amp;lt;BR&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;De voorwaarden van gebruik staan op de beginpagina&amp;lt;!--ftConditions--&amp;gt; [[Bestand:list2.png|link=ZIB_Hoofdpagina&amp;lt;!--wikiMainpage--&amp;gt;]]&amp;lt;BR&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Deze pagina is gegenereerd op 17/04/2026 &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;11&lt;/del&gt;:&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;22&lt;/del&gt;:&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;42 &lt;/del&gt;met ZibExtraction v. 10.0.9603.19166&amp;lt;!--ftDate--&amp;gt; &amp;lt;BR&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Deze pagina is gegenereerd op 17/04/2026 &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;12&lt;/ins&gt;:&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;06&lt;/ins&gt;:&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;19 &lt;/ins&gt;met ZibExtraction v. 10.0.9603.19166&amp;lt;!--ftDate--&amp;gt; &amp;lt;BR&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;-----&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;-----&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;div style=&amp;quot;text-align: right; direction: ltr; margin-left: 1em;&amp;quot; &amp;gt;[[Bestand: Back 16.png| link= ZIB_Publicatie&amp;lt;!--wikiReleasePage--&amp;gt;_2026-1(NL)]] [[ZIB_Publicatie&amp;lt;!--wikiReleasePage--&amp;gt;_2026-1(NL) |Terug naar ZIB overzicht&amp;lt;!--hdBackToMainPage--&amp;gt; ]]&amp;lt;/div&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;div style=&amp;quot;text-align: right; direction: ltr; margin-left: 1em;&amp;quot; &amp;gt;[[Bestand: Back 16.png| link= ZIB_Publicatie&amp;lt;!--wikiReleasePage--&amp;gt;_2026-1(NL)]] [[ZIB_Publicatie&amp;lt;!--wikiReleasePage--&amp;gt;_2026-1(NL) |Terug naar ZIB overzicht&amp;lt;!--hdBackToMainPage--&amp;gt; ]]&amp;lt;/div&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Update bot</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=DrugsGebruik-v3.5(2026-1NL)&amp;diff=33762&amp;oldid=prev</id>
		<title>Update bot: Nieuwe pagina aangemaakt met &#039;&lt;!-- Hieronder wordt een transclude page aangeroepen --&gt;  {{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.7.4(NL)|1|DrugsGebruik-v3.5(2026-1NL)}}  &lt;!-- Tot hier de transclude page --&gt;  ==Algemeen&lt;!--hdGeneralInformation--&gt;==  Naam&lt;!--hdName--&gt;: &#039;&#039;&#039;nl.zorg.DrugsGebruik&#039;&#039;&#039; link=DrugUse-v3.5(2026-1EN)&lt;BR&gt;  Versie&lt;!--hdVersion--&gt;: &#039;&#039;&#039;3.5&#039;&#039;&#039; &lt;br&gt;  ZIB Status&lt;!--hdStatus--&gt;:Draft&lt;br&gt;  Publicatie&lt;!--hdPublication--&gt;: &#039;&#039;&#039;2026-1&#039;&#039;&#039; &lt;br&gt;  Publicatie sta…&#039;</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=DrugsGebruik-v3.5(2026-1NL)&amp;diff=33762&amp;oldid=prev"/>
		<updated>2026-04-17T09:47:37Z</updated>

		<summary type="html">&lt;p&gt;Nieuwe pagina aangemaakt met &amp;#039;&amp;lt;!-- Hieronder wordt een transclude page aangeroepen --&amp;gt;  {{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.7.4(NL)|1|DrugsGebruik-v3.5(2026-1NL)}}  &amp;lt;!-- Tot hier de transclude page --&amp;gt;  ==Algemeen&amp;lt;!--hdGeneralInformation--&amp;gt;==  Naam&amp;lt;!--hdName--&amp;gt;: &amp;#039;&amp;#039;&amp;#039;nl.zorg.DrugsGebruik&amp;#039;&amp;#039;&amp;#039; &lt;a href=&quot;/wiki/Bestand:EN.png&quot; title=&quot;Bestand:EN.png&quot;&gt;link=DrugUse-v3.5(2026-1EN)&lt;/a&gt;&amp;lt;BR&amp;gt;  Versie&amp;lt;!--hdVersion--&amp;gt;: &amp;#039;&amp;#039;&amp;#039;3.5&amp;#039;&amp;#039;&amp;#039; &amp;lt;br&amp;gt;  ZIB Status&amp;lt;!--hdStatus--&amp;gt;:Draft&amp;lt;br&amp;gt;  Publicatie&amp;lt;!--hdPublication--&amp;gt;: &amp;#039;&amp;#039;&amp;#039;2026-1&amp;#039;&amp;#039;&amp;#039; &amp;lt;br&amp;gt;  Publicatie sta…&amp;#039;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Nieuwe pagina&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&amp;lt;!-- Hieronder wordt een transclude page aangeroepen --&amp;gt;&lt;br /&gt;
{{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.7.4(NL)|1|DrugsGebruik-v3.5(2026-1NL)}}&lt;br /&gt;
&amp;lt;!-- Tot hier de transclude page --&amp;gt;&lt;br /&gt;
==Algemeen&amp;lt;!--hdGeneralInformation--&amp;gt;==&lt;br /&gt;
Naam&amp;lt;!--hdName--&amp;gt;: &amp;#039;&amp;#039;&amp;#039;nl.zorg.DrugsGebruik&amp;#039;&amp;#039;&amp;#039; [[Bestand:EN.png|link=DrugUse-v3.5(2026-1EN)]]&amp;lt;BR&amp;gt;&lt;br /&gt;
Versie&amp;lt;!--hdVersion--&amp;gt;: &amp;#039;&amp;#039;&amp;#039;3.5&amp;#039;&amp;#039;&amp;#039; &amp;lt;br&amp;gt;&lt;br /&gt;
ZIB Status&amp;lt;!--hdStatus--&amp;gt;:Draft&amp;lt;br&amp;gt;&lt;br /&gt;
Publicatie&amp;lt;!--hdPublication--&amp;gt;: &amp;#039;&amp;#039;&amp;#039;2026-1&amp;#039;&amp;#039;&amp;#039; &amp;lt;br&amp;gt;&lt;br /&gt;
Publicatie status&amp;lt;!--hdPublicationStatus--&amp;gt;: Unpublished&amp;lt;br&amp;gt;&lt;br /&gt;
Publicatie datum&amp;lt;!--hdPublicationDate--&amp;gt;: &lt;br /&gt;
&amp;lt;!-- Aanroep Errata transclude page --&amp;gt;&lt;br /&gt;
{{Errata&amp;lt;!--hdErrata--&amp;gt;|2026-1|{{PAGENAME}}}}&lt;br /&gt;
&amp;lt;!-- tot hier --&amp;gt;&lt;br /&gt;
-----&lt;br /&gt;
&amp;lt;div style=&amp;quot;text-align: right; direction: ltr; margin-left: 1em;&amp;quot; &amp;gt;[[Bestand: Back 16.png| link= ZIB_Publicatie&amp;lt;!--wikiReleasePage--&amp;gt;_2026-1(NL)]] [[ZIB_Publicatie&amp;lt;!--wikiReleasePage--&amp;gt;_2026-1(NL) |Terug naar ZIB overzicht&amp;lt;!--hdBackToMainPage--&amp;gt; ]]&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Metadata==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;font-size:90%; width: 750px&amp;quot;&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::CoderList||Kerngroep Registratie aan de Bron&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::ContactInformation.Address||*&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::ContactInformation.Name||*&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::ContactInformation.Telecom||*&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::ContentAuthorList||Projectgroep Generieke Overdrachtsgegevens &amp;amp; Kerngroep Registratie aan de Bron&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::CreationDate||5-7-2012&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::DeprecatedDate||&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::DescriptionLanguage||nl&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::EndorsingAuthority.Address||&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::EndorsingAuthority.Name||PM&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::EndorsingAuthority.Telecom||&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::Id||2.16.840.1.113883.2.4.3.11.60.40.3.7.4&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::KeywordList||drugsgebruik, verdovende middelen, middelen gebruik, drugs&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::LifecycleStatus||Draft&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::ModelerList||Kerngroep Registratie aan de Bron&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::Name||nl.zorg.DrugsGebruik&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::PublicationDate||&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::PublicationStatus||Unpublished&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::ReviewerList||Projectgroep Generieke Overdrachtsgegevens &amp;amp; Kerngroep Registratie aan de Bron&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::RevisionDate||05-04-2024&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::Supersedes||nl.zorg.DrugsGebruik-v3.4.1&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::Version||3.5&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|HCIM::PublicationLanguage||NL&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Revision History==&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039; &amp;lt;!--noTranslation--&amp;gt;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;u&amp;gt;Publicatieversie 1.0&amp;lt;/u&amp;gt; (15-02-2013)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;u&amp;gt;Publicatieversie 1.1&amp;lt;/u&amp;gt; (01-07-2013)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;u&amp;gt;Publicatieversie 1.2&amp;lt;/u&amp;gt; (01-04-2015)&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues500_0#ZIB-138 | ZIB-138 ]]&lt;br /&gt;
|Aanpassingen in SNOMED CT codes en omschrijvingen voor codelijst DrugsGebruikStatusCodelijst n.a.v. review terminologie expert.&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues500_0#ZIB-139 | ZIB-139 ]]&lt;br /&gt;
|Aanpassingen in SNOMED CT codes en omschrijvingen voor codelijst DrugsOfGeneesmiddelSoortCodelijst n.a.v. review terminologie expert.&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues500_0#ZIB-158 | ZIB-158 ]]&lt;br /&gt;
|Cardinaliteit SoortMiddel aanpassen in bouwsteen OverdrachtDrugsgebruik&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues500_0#ZIB-161 | ZIB-161 ]]&lt;br /&gt;
|Het concept Hoeveelheid van bouwsteen OverdrachtDrugsgebruik.&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues500_0#ZIB-167 | ZIB-167 ]]&lt;br /&gt;
|Bevindingen Concept inrichting Intoxicatie Roken/ Alcohol en Drugs in EZIS.NET&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues500_0#ZIB-224 | ZIB-224 ]]&lt;br /&gt;
|In de klinische bouwsteen OverdrachtDrugsgebruik, concept SoortMiddel komt tagged value DrugsOfGeneesmiddelSoortCodelijst niet overeen met naam gekoppelde valueset DrugsOfGeneesmiddelSoort.&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues500_0#ZIB-225 | ZIB-225 ]]&lt;br /&gt;
|In de klinische bouwsteen OverdrachtDrugsgebruik, concept ToedieningsWeg komt tagged value ToedieningsWegCodelijst niet overeen met naam gekoppelde valueset.&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues500_0#ZIB-308 | ZIB-308 ]]&lt;br /&gt;
|Prefix Overdracht weggehaald bij de generieke bouwstenen&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues500_0#ZIB-312 | ZIB-312 ]]&lt;br /&gt;
|aanpassing paragraaf &amp;#039;Concept&amp;#039;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues500_0#ZIB-313 | ZIB-313 ]]&lt;br /&gt;
|Aanpassen paragraaf &amp;#039;Purpose&amp;#039;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues500_0#ZIB-316 | ZIB-316 ]]&lt;br /&gt;
|Paragraaf &amp;#039;Evidence base&amp;#039; wijzigen&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues500_0#ZIB-319 | ZIB-319 ]]&lt;br /&gt;
|Wijzing paragraaf Constraint&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
Incl. algemene wijzigingsverzoeken: &lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues500_0#ZIB-94 | ZIB-94 ]]&lt;br /&gt;
|Aanpassen tekst van Disclaimer, Terms of Use &amp;amp; Copyrights&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues500_0#ZIB-154 | ZIB-154 ]]&lt;br /&gt;
|Consequenties opsplitsing Medicatie bouwstenen voor overige bouwstenen.&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues500_0#ZIB-200 | ZIB-200 ]]&lt;br /&gt;
|Naamgeving SNOMED CT in tagged values klinische bouwstenen gelijk getrokken.&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues500_0#ZIB-201 | ZIB-201 ]]&lt;br /&gt;
|Naamgeving OID: in tagged value notes van klinische bouwstenen gelijk getrokken.&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues500_0#ZIB-309 | ZIB-309 ]]&lt;br /&gt;
|EOI aangepast&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues500_0#ZIB-324 | ZIB-324 ]]&lt;br /&gt;
|Codelijsten Name en Description beginnen met een Hoofdletter&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues500_0#ZIB-326 | ZIB-326 ]]&lt;br /&gt;
|Tekstuele aanpassingen conform de kwaliteitsreview kerngroep 2015&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;u&amp;gt;Publicatieversie 1.2.1&amp;lt;/u&amp;gt; (22-05-2015)&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues500_0#ZIB-388 | ZIB-388 ]]&lt;br /&gt;
|De ToedieningswegCodelijst heeft geen &amp;quot;OID: &amp;quot; aanduiding in de onderliggende codelijst.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;u&amp;gt;Publicatieversie 1.2.2&amp;lt;/u&amp;gt; (16-07-2015)&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues500_0#ZIB-418 | ZIB-418 ]]&lt;br /&gt;
|Vervallen SNOMED CT code in DrugsOfGeneesmiddelSoortCodelijst&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;u&amp;gt;Publicatieversie 3.0&amp;lt;/u&amp;gt; (01-05-2016)&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues500_0#ZIB-453 | ZIB-453 ]]&lt;br /&gt;
|Wijziging naamgeving ZIB&amp;#039;s en logo&amp;#039;s door andere opzet van beheer&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;u&amp;gt;Publicatieversie 3.1&amp;lt;/u&amp;gt; (04-09-2017)&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues500_0#ZIB-475 | ZIB-475 ]]&lt;br /&gt;
|Terminologiekoppeling Drugsgebruik&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues500_0#ZIB-488 | ZIB-488 ]]&lt;br /&gt;
|niet compleet&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues500_1#ZIB-505 | ZIB-505 ]]&lt;br /&gt;
|Geen informatie&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues500_1#ZIB-512 | ZIB-512 ]]&lt;br /&gt;
|Hoe houd je verschillende adresgegevens uit elkaar?&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues500_1#ZIB-564 | ZIB-564 ]]&lt;br /&gt;
|Aanpassing/harmonisatie Engelse conceptnamen&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
Publicatieversie &amp;lt;u&amp;gt;3.2&amp;lt;/u&amp;gt; (31-12-2017)&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues500_1#ZIB-555 | ZIB-555 ]]&lt;br /&gt;
|Uitbreiding codelijst van ZIB DrugsGebruik&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
Publicatieversie &amp;lt;u&amp;gt;3.3&amp;lt;/u&amp;gt; (01-09-2020)&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues500_1#ZIB-936 | ZIB-936 ]]&lt;br /&gt;
|DrugsGebruikStatusCodelijst vertalingen corrigeren&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues500_2#ZIB-1181 | ZIB-1181 ]]&lt;br /&gt;
|DefinitionCodes zib drugGebruik&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
Publicatieversie &amp;lt;u&amp;gt;3.4&amp;lt;/u&amp;gt; (01-12-2021)&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues500_2#ZIB-1009 | ZIB-1009 ]]&lt;br /&gt;
|Aanvullingen zib druggebruik: waardenlijst middelen&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues500_2#ZIB-1302 | ZIB-1302 ]]&lt;br /&gt;
|Uitbreiding DrugsOfGeneesmiddelSoortCodelijst van de zib DrugsGebruik&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues500_3#ZIB-1575 | ZIB-1575 ]]&lt;br /&gt;
|Deprecated termen en waardelijsten uit de prepublicatie halen&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
Publicatieversie &amp;lt;u&amp;gt;3.4.1&amp;lt;/u&amp;gt; (15-10-2023)&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues500_3#ZIB-1974 | ZIB-1974 ]]&lt;br /&gt;
|Suggested typo and textual improvements&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
Publicatieversie &amp;lt;u&amp;gt;3.5&amp;lt;/u&amp;gt; (15-04-2024)&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues500_4#ZIB-2146 | ZIB-2146 ]]&lt;br /&gt;
|Toevoegen definitiecodes voor concepten Hoeveelheid en DrugsOfGeneesmiddelSoort&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Concept==&lt;br /&gt;
Drugs (ook wel: verdovende middelen, stimulerende middelen, bedwelmingsmiddelen, roesmiddelen, geestverruimende middelen, verboden middelen of dope) is een verzamelnaam voor geneesmiddelen en genotsmiddelen die een meer of minder &amp;#039;drogerende&amp;#039; (verdovende, opwekkende en/of hallucinogene) werking hebben en die tot verslaving kunnen leiden. Drug [Online] Beschikbaar op:  nl.Wikipedia.org/wiki/drug [Geraadpleegd: 11 februari 2015].&amp;lt;BR&amp;gt;&lt;br /&gt;
&amp;lt;BR&amp;gt;&lt;br /&gt;
Deze bouwsteen beschrijft de bij de patiënt uitgevraagde gegevens over het gebruik van drugs.&lt;br /&gt;
&lt;br /&gt;
==Purpose==&lt;br /&gt;
Vastleggen en delen van de registratie van het gebruik van drugs, zoals in het concept beschreven.&lt;br /&gt;
&lt;br /&gt;
==Evidence Base==&lt;br /&gt;
Hoewel deze bouwsteen ook gebruikt kan worden voor misbruik van (eigen) medicatie heeft de projectgroep uiteindelijk besloten de focus op de gegevens over drugsgebruik, zoals beschreven in het concept. &amp;lt;BR&amp;gt;&lt;br /&gt;
Aangezien er grote diversiteit is in de wijze waarop de hoeveelheid gebruikte drugs wordt vastgelegd, is besloten dit als vrije tekst te doen.&lt;br /&gt;
&lt;br /&gt;
==Information Model==&lt;br /&gt;
&amp;lt;BR&amp;gt;&lt;br /&gt;
&amp;lt;imagemap&amp;gt; Bestand:DrugsGebruik-v3.5Model(2026-1NL).png | center &lt;br /&gt;
rect 526 241 671 311 [[#647]]&lt;br /&gt;
rect 703 251 880 301 [[#ToedieningswegCodelijst]]&lt;br /&gt;
rect 704 151 881 201 [[#DrugsGebruikStatusCodelijst]]&lt;br /&gt;
rect 358 360 448 430 [[#652]]&lt;br /&gt;
rect 342 235 466 305 [[#645]]&lt;br /&gt;
rect 706 63 915 113 [[#DrugsOfGeneesmiddelSoortCodelijst]]&lt;br /&gt;
rect 526 139 671 209 [[#646]]&lt;br /&gt;
rect 526 50 671 120 [[#650]]&lt;br /&gt;
rect 177 308 271 378 [[#642]]&lt;br /&gt;
rect 177 209 271 279 [[#649]]&lt;br /&gt;
rect 342 107 466 188 [[#643]]&lt;br /&gt;
rect 177 112 271 182 [[#641]]&lt;br /&gt;
desc none&lt;br /&gt;
&amp;lt;/imagemap&amp;gt;&lt;br /&gt;
&amp;lt;BR&amp;gt;&lt;br /&gt;
{| border= &amp;quot;1&amp;quot;  width=&amp;quot;1500px&amp;quot; style = &amp;quot;font-size: 9.5pt;  border: solid 1px silver; border-collapse:collapse;&amp;quot; cellpadding = &amp;quot;3px&amp;quot; cellspacing =&amp;quot;0px&amp;quot; &lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; font-variant: small-caps; &amp;quot;&lt;br /&gt;
|style=&amp;quot;width:30px;&amp;quot;|Type&amp;lt;!--imType--&amp;gt;||style=&amp;quot;width:100px;&amp;quot;|Id&amp;lt;!--imId--&amp;gt;||colspan=&amp;quot;6 &amp;quot; style=&amp;quot;width:140px;&amp;quot;|Concept&amp;lt;!--imConcept--&amp;gt;||Card.&amp;lt;!--imCard--&amp;gt;||style=&amp;quot;width: 600px;&amp;quot;|Definitie&amp;lt;!--imDefinition--&amp;gt;||style=&amp;quot;width:200px;&amp;quot;|DefinitieCode&amp;lt;!--imDefinitionCode--&amp;gt;||style=&amp;quot;width:200px;&amp;quot;|Verwijzing&amp;lt;!--imReference--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: #E3E3E3; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: block.png| 20px | link=]]&lt;br /&gt;
||NL-CM:7.4.1&lt;br /&gt;
|colspan =&amp;quot;6&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=643 Title=&amp;quot;EN: DrugUse&amp;quot;&amp;gt;[[Bestand: arrowdown.png | 10px | link=]]DrugsGebruik&amp;lt;/span&amp;gt;&lt;br /&gt;
|&lt;br /&gt;
|Rootconcept van de bouwsteen DrugsGebruik. Dit concept bevat alle gegevenselementen van de bouwsteen DrugsGebruik.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT; Finding relating to drug misuse behavior (finding)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=228366006 228366006] Bevinding betreffende drugsgebruik&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: #E8D7BE; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: folder.png| 16px | link=]]&lt;br /&gt;
||NL-CM:7.4.5&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=645 Title=&amp;quot;EN: ObservationOfUse&amp;quot;&amp;gt;[[Bestand: arrowdown.png | 10px | link=]]WaarnemingGebruik&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Container voor WaarnemingGebruik. Deze container bevat alle gegevenselementen van de container WaarnemingGebruik.&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: TS.png| 16px | link=]]&lt;br /&gt;
||NL-CM:7.4.6&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;4&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=649 Title=&amp;quot;EN: StartDate&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]StartDatum&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|De datum waarop is gestart met het gebruik. &lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: TS.png| 16px | link=]]&lt;br /&gt;
||NL-CM:7.4.7&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;4&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=642 Title=&amp;quot;EN: StopDate&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]StopDatum&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|De datum waarop is gestopt met het gebruik.&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: ST.png| 16px | link=]]&lt;br /&gt;
||NL-CM:7.4.8&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;4&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=652 Title=&amp;quot;EN: Amount&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]Hoeveelheid&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Het aantal eenheden (pillen, joints, shots etc.) per dag, week, maand of jaar of de freqentie van gebruik.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT; Frequency of drug misuse (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=228390007 228390007] Frequentie van drugsmisbruik&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: ST.png| 16px | link=]]&lt;br /&gt;
||NL-CM:7.4.9&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=641 Title=&amp;quot;EN: Comment&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]Toelichting&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Relevante opmerkingen over het gebruik.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: LOINC; Annotation comment [Interpretation] Narrative (Nar)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/loinc?conceptId=48767-8 48767-8] Verklarend commentaar [interpretatie] in {systeem} (tekstueel)&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: CD.png| 16px | link=]]&lt;br /&gt;
||NL-CM:7.4.2&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=650 Title=&amp;quot;EN: DrugOrMedicationType&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]DrugsOfGeneesmiddelSoort&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Soort drugs die de patiënt gebruikt.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT; Drug or medicament (substance)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=410942007 410942007] Drug of geneesmiddel&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#DrugsOfGeneesmiddelSoortCodelijst]]||[[#DrugsOfGeneesmiddelSoortCodelijst|DrugsOfGeneesmiddelSoortCodelijst]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: CD.png| 16px | link=]]&lt;br /&gt;
||NL-CM:7.4.3&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=646 Title=&amp;quot;EN: DrugUseStatus&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]DrugsGebruikStatus&amp;lt;/span&amp;gt;&lt;br /&gt;
|1&lt;br /&gt;
|Indicatie of in het heden of verleden sprake is (geweest) van gebruik van drugs.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT; Finding relating to drug misuse behavior (finding)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=228366006 228366006] Bevinding betreffende drugsgebruik&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#DrugsGebruikStatusCodelijst]]||[[#DrugsGebruikStatusCodelijst|DrugsGebruikStatusCodelijst]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: CD.png| 16px | link=]]&lt;br /&gt;
||NL-CM:7.4.4&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=647 Title=&amp;quot;EN: RouteOfAdministration&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]Toedieningsweg&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..*&lt;br /&gt;
|De wijze de drugs wordt gebruikt.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT; Route of administration (attribute)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=410675002 410675002] Toedieningsweg&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#ToedieningswegCodelijst]]||[[#ToedieningswegCodelijst|ToedieningswegCodelijst]]&lt;br /&gt;
|}&lt;br /&gt;
|}&lt;br /&gt;
Kolommen Concept en DefinitieCode: houdt de muis boven de waarde voor meer informatie&amp;lt;!--imHover--&amp;gt;&amp;lt;BR&amp;gt;&lt;br /&gt;
Voor uitleg over de gebruikte symbolen, zie de legenda pagina&amp;lt;!--imLegend--&amp;gt; [[Bestand:list2.png|link=Legenda&amp;lt;!--wikiLegend--&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
==Example Instances==&lt;br /&gt;
{|class=&amp;quot;wikitable&amp;quot; width=&amp;quot;791px&amp;quot; style= &amp;quot;font-size: 9.5pt;&amp;quot;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;background-color: #1F497D; width: 10%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;DrugsOfGeneesmiddel&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #1F497D; width: 17%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;Drugs Gebruik &amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;Status&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #1F497D; width: 14%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;Start datum&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #1F497D; width: 9%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;Stop datum&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #1F497D; width: 14%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;Toedieningsweg&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #1F497D; width: 16%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;Hoeveelheid&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #1F497D; width: 20%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;Toelichting&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;width: 10%; &amp;quot;|XTC&lt;br /&gt;
| style=&amp;quot;width: 17%; &amp;quot;|misbruikt drugs&lt;br /&gt;
| style=&amp;quot;width: 14%; &amp;quot;|1985&lt;br /&gt;
| style=&amp;quot;width: 9%; &amp;quot;|&lt;br /&gt;
| style=&amp;quot;width: 14%; &amp;quot;|oraal&lt;br /&gt;
| style=&amp;quot;width: 16%; &amp;quot;|2x per maand&lt;br /&gt;
| style=&amp;quot;width: 20%; &amp;quot;|Op feestjes en in uitgaanscircuit. Vroeger wat meer dan tegenwoordig.&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;background-color: #1F497D; width: 10%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;DrugsOfGeneesmiddel&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #1F497D; width: 17%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;Drugs Gebruik Status&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #1F497D; width: 14%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;Start datum&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #1F497D; width: 9%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;Stop datum&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #1F497D; width: 14%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;Toedieningsweg&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #1F497D; width: 16%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;Hoeveelheid&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #1F497D; width: 20%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;Toelichting&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;width: 10%; &amp;quot;|Heroïne&lt;br /&gt;
| style=&amp;quot;width: 17%; &amp;quot;|heeft in het verleden drugs gebruikt&lt;br /&gt;
| style=&amp;quot;width: 14%; &amp;quot;|1970&lt;br /&gt;
| style=&amp;quot;width: 9%; &amp;quot;|1985&lt;br /&gt;
| style=&amp;quot;width: 14%; &amp;quot;|intraveneus&lt;br /&gt;
| style=&amp;quot;width: 16%; &amp;quot;|3x per week&lt;br /&gt;
| style=&amp;quot;width: 20%; &amp;quot;|&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Instructions==&lt;br /&gt;
De &amp;#039;DrugsOfGeneesmiddelCodelijst is uitbreidbaar. Indien het betreffende middel niet in de codelijst staat, kan deze lijst uitgebreid worden met een code uit de SNOMED CT hiërarchie &amp;#039;Substance; &amp;lt;105590001&amp;#039; of eventueel  uit de hiërarchie &amp;#039;Pharmaceutical/biologic product; &amp;lt; 373873005&amp;#039;&lt;br /&gt;
&lt;br /&gt;
== Valuesets ==&lt;br /&gt;
=== DrugsGebruikStatusCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&amp;#039;vertical-align:top; background-color: #E8D7BE;&amp;#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.2&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|Status&amp;lt;!--vsStatusTag--&amp;gt;: Active&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Current drug user (finding)&amp;quot;&amp;gt;Huidige drugsgebruiker&amp;lt;/span&amp;gt;&lt;br /&gt;
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=417284009 417284009]&lt;br /&gt;
|SNOMED CT&lt;br /&gt;
|2.16.840.1.113883.6.96&lt;br /&gt;
|huidige drugsgebruiker&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Does not misuse drugs (situation)&amp;quot;&amp;gt;Gebruikt geen drugs&amp;lt;/span&amp;gt;&lt;br /&gt;
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=228367002 228367002]&lt;br /&gt;
|SNOMED CT&lt;br /&gt;
|2.16.840.1.113883.6.96&lt;br /&gt;
|gebruikt geen drugs&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Has never misused drugs (situation)&amp;quot;&amp;gt;Heeft nooit drugs gebruikt&amp;lt;/span&amp;gt;&lt;br /&gt;
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=228368007 228368007]&lt;br /&gt;
|SNOMED CT&lt;br /&gt;
|2.16.840.1.113883.6.96&lt;br /&gt;
|heeft nooit drugs gebruikt&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Misused drugs in past (finding)&amp;quot;&amp;gt;Ex-gebruiker van drugs&amp;lt;/span&amp;gt;&lt;br /&gt;
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=44870007 44870007]&lt;br /&gt;
|SNOMED CT&lt;br /&gt;
|2.16.840.1.113883.6.96&lt;br /&gt;
|heeft in het verleden drugs gebruikt&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|colspan=&amp;quot;5&amp;quot;|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: #EBF5FB;&amp;quot;&lt;br /&gt;
|colspan=&amp;quot;5&amp;quot;|Waarde Other (OTH) uit codestelsel NullFlavor (OID: 2.16.840.1.113883.5.1008) is toegestaan in deze waardenlijst.&amp;lt;!--vsIncludeOTH--&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
=== DrugsOfGeneesmiddelSoortCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&amp;#039;vertical-align:top; background-color: #E8D7BE;&amp;#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.1&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|Status&amp;lt;!--vsStatusTag--&amp;gt;: Active&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Diamorphine (substance)&amp;quot;&amp;gt;Heroïne&amp;lt;/span&amp;gt;&lt;br /&gt;
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=387341002 387341002]&lt;br /&gt;
|SNOMED CT&lt;br /&gt;
|2.16.840.1.113883.6.96&lt;br /&gt;
|Heroïne&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Benzodiazepine (substance)&amp;quot;&amp;gt;Benzodiazepine&amp;lt;/span&amp;gt;&lt;br /&gt;
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=372664007 372664007]&lt;br /&gt;
|SNOMED CT&lt;br /&gt;
|2.16.840.1.113883.6.96&lt;br /&gt;
|Benzodiazepine&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Methadone (substance)&amp;quot;&amp;gt;Methadon&amp;lt;/span&amp;gt;&lt;br /&gt;
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=387286002 387286002]&lt;br /&gt;
|SNOMED CT&lt;br /&gt;
|2.16.840.1.113883.6.96&lt;br /&gt;
|Methadon&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Hydroxybutyric acid (substance)&amp;quot;&amp;gt;Hydroxyboterzuur&amp;lt;/span&amp;gt;&lt;br /&gt;
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=62821004 62821004]&lt;br /&gt;
|SNOMED CT&lt;br /&gt;
|2.16.840.1.113883.6.96&lt;br /&gt;
|GHB&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Cocaine (substance)&amp;quot;&amp;gt;Cocaïne&amp;lt;/span&amp;gt;&lt;br /&gt;
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=387085005 387085005]&lt;br /&gt;
|SNOMED CT&lt;br /&gt;
|2.16.840.1.113883.6.96&lt;br /&gt;
|Cocaïne&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Cocaine freebase (substance)&amp;quot;&amp;gt;Crack&amp;lt;/span&amp;gt;&lt;br /&gt;
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=229003004 229003004]&lt;br /&gt;
|SNOMED CT&lt;br /&gt;
|2.16.840.1.113883.6.96&lt;br /&gt;
|Crack, base coke&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Methylenedioxymethamphetamine (substance)&amp;quot;&amp;gt;Methyleendioxymethamfetamine&amp;lt;/span&amp;gt;&lt;br /&gt;
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=288459003 288459003]&lt;br /&gt;
|SNOMED CT&lt;br /&gt;
|2.16.840.1.113883.6.96&lt;br /&gt;
|MDMA&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Amphetamine (substance)&amp;quot;&amp;gt;Amfetamine&amp;lt;/span&amp;gt;&lt;br /&gt;
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=703842006 703842006]&lt;br /&gt;
|SNOMED CT&lt;br /&gt;
|2.16.840.1.113883.6.96&lt;br /&gt;
|Amfetamine, speed&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Cannabis (substance)&amp;quot;&amp;gt;Cannabis&amp;lt;/span&amp;gt;&lt;br /&gt;
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=398705004 398705004]&lt;br /&gt;
|SNOMED CT&lt;br /&gt;
|2.16.840.1.113883.6.96&lt;br /&gt;
|Cannabis, wiet marihuana, hasj&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Hallucinogenic mushrooms (substance)&amp;quot;&amp;gt;Paddo&amp;lt;/span&amp;gt;&lt;br /&gt;
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=229006007 229006007]&lt;br /&gt;
|SNOMED CT&lt;br /&gt;
|2.16.840.1.113883.6.96&lt;br /&gt;
|Paddo&amp;#039;s&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Lysergic acid diethylamide (substance)&amp;quot;&amp;gt;LSD&amp;lt;/span&amp;gt;&lt;br /&gt;
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=15698006 15698006]&lt;br /&gt;
|SNOMED CT&lt;br /&gt;
|2.16.840.1.113883.6.96&lt;br /&gt;
|LSD&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Ketamine (substance)&amp;quot;&amp;gt;Ketamine&amp;lt;/span&amp;gt;&lt;br /&gt;
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=373464007 373464007]&lt;br /&gt;
|SNOMED CT&lt;br /&gt;
|2.16.840.1.113883.6.96&lt;br /&gt;
|Ketamine&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Phencyclidine (substance)&amp;quot;&amp;gt;Fencyclidine&amp;lt;/span&amp;gt;&lt;br /&gt;
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=9721008 9721008]&lt;br /&gt;
|SNOMED CT&lt;br /&gt;
|2.16.840.1.113883.6.96&lt;br /&gt;
|PCP&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Methamphetamine (substance)&amp;quot;&amp;gt;Methamfetamine&amp;lt;/span&amp;gt;&lt;br /&gt;
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=387499002 387499002]&lt;br /&gt;
|SNOMED CT&lt;br /&gt;
|2.16.840.1.113883.6.96&lt;br /&gt;
|Crystal meth, methamfetamine&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Anabolic androgenic steroid (substance)&amp;quot;&amp;gt;Anabool steroïd&amp;lt;/span&amp;gt;&lt;br /&gt;
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=111151007 111151007]&lt;br /&gt;
|SNOMED CT&lt;br /&gt;
|2.16.840.1.113883.6.96&lt;br /&gt;
|Anabole steroïde&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Laxative (substance)&amp;quot;&amp;gt;Laxans&amp;lt;/span&amp;gt;&lt;br /&gt;
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=372800002 372800002]&lt;br /&gt;
|SNOMED CT&lt;br /&gt;
|2.16.840.1.113883.6.96&lt;br /&gt;
|Laxans&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Buprenorphine (substance)&amp;quot;&amp;gt;Buprenorfine&amp;lt;/span&amp;gt;&lt;br /&gt;
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=387173000 387173000]&lt;br /&gt;
|SNOMED CT&lt;br /&gt;
|2.16.840.1.113883.6.96&lt;br /&gt;
|Buprenorfine&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Fentanyl (substance)&amp;quot;&amp;gt;Fentanyl&amp;lt;/span&amp;gt;&lt;br /&gt;
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=373492002 373492002]&lt;br /&gt;
|SNOMED CT&lt;br /&gt;
|2.16.840.1.113883.6.96&lt;br /&gt;
|Fentanyl&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Barbiturate (substance)&amp;quot;&amp;gt;Barbituraat&amp;lt;/span&amp;gt;&lt;br /&gt;
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=372798009 372798009]&lt;br /&gt;
|SNOMED CT&lt;br /&gt;
|2.16.840.1.113883.6.96&lt;br /&gt;
|Barbituraat&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Opioid receptor agonist (substance)&amp;quot;&amp;gt;Opioïdreceptoragonist&amp;lt;/span&amp;gt;&lt;br /&gt;
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=404642006 404642006]&lt;br /&gt;
|SNOMED CT&lt;br /&gt;
|2.16.840.1.113883.6.96&lt;br /&gt;
|Opiaten zoals morfine, codeïne, methadon, oxycodon en andere morfine-derivaten&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|&amp;lt;span title = &amp;quot;4-Fluoroamphetamine (substance)&amp;quot;&amp;gt;4-fluoramfetamine&amp;lt;/span&amp;gt;&lt;br /&gt;
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=33471000146101 33471000146101]&lt;br /&gt;
|SNOMED CT&lt;br /&gt;
|2.16.840.1.113883.6.96&lt;br /&gt;
|4FA en/of 4-fmp&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Oxycodone (substance)&amp;quot;&amp;gt;Oxycodon&amp;lt;/span&amp;gt;&lt;br /&gt;
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=55452001 55452001]&lt;br /&gt;
|SNOMED CT&lt;br /&gt;
|2.16.840.1.113883.6.96&lt;br /&gt;
|Oxycodon&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Nitrous oxide (substance)&amp;quot;&amp;gt;Distikstofmonoxide&amp;lt;/span&amp;gt;&lt;br /&gt;
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=111132001 111132001]&lt;br /&gt;
|SNOMED CT&lt;br /&gt;
|2.16.840.1.113883.6.96&lt;br /&gt;
|Lachgas&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|colspan=&amp;quot;5&amp;quot;|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: #EBF5FB;&amp;quot;&lt;br /&gt;
|colspan=&amp;quot;5&amp;quot;|Waarde Other (OTH) uit codestelsel NullFlavor (OID: 2.16.840.1.113883.5.1008) is toegestaan in deze waardenlijst.&amp;lt;!--vsIncludeOTH--&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
=== ToedieningswegCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&amp;#039;vertical-align:top; background-color: #E8D7BE;&amp;#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.3&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|Status&amp;lt;!--vsStatusTag--&amp;gt;: Active&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ORAAL&lt;br /&gt;
|9&lt;br /&gt;
|G-Standaard Toedieningswegen&lt;br /&gt;
|2.16.840.1.113883.2.4.4.9&lt;br /&gt;
|oraal&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|NASAAL&lt;br /&gt;
|6&lt;br /&gt;
|G-Standaard Toedieningswegen&lt;br /&gt;
|2.16.840.1.113883.2.4.4.9&lt;br /&gt;
|nasaal (snuiven)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|INHALATIE&lt;br /&gt;
|62&lt;br /&gt;
|G-Standaard Toedieningswegen&lt;br /&gt;
|2.16.840.1.113883.2.4.4.9&lt;br /&gt;
|Inhalatie (roken)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|INTRAVENEUS&lt;br /&gt;
|5&lt;br /&gt;
|G-Standaard Toedieningswegen&lt;br /&gt;
|2.16.840.1.113883.2.4.4.9&lt;br /&gt;
|Intraveneus (spuiten)&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|colspan=&amp;quot;5&amp;quot;|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: #EBF5FB;&amp;quot;&lt;br /&gt;
|colspan=&amp;quot;5&amp;quot;|Waarde Other (OTH) uit codestelsel NullFlavor (OID: 2.16.840.1.113883.5.1008) is toegestaan in deze waardenlijst.&amp;lt;!--vsIncludeOTH--&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Deze bouwsteen in overige publicaties&amp;lt;!--ftOtherReleases--&amp;gt;==&lt;br /&gt;
&amp;lt;!-- Hieronder wordt een transclude page aangeroepen --&amp;gt;&lt;br /&gt;
{{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.7.4(NL)|2|2026-1}}&lt;br /&gt;
&amp;lt;!-- Tot hier de transclude page --&amp;gt;&lt;br /&gt;
==Bouwsteen verwijzingen&amp;lt;!--ftReferences--&amp;gt;==&lt;br /&gt;
====Deze bouwsteen verwijst naar&amp;lt;!--ftRefersTo--&amp;gt;====&lt;br /&gt;
:--&lt;br /&gt;
====Deze bouwsteen wordt gebruikt in&amp;lt;!--ftReferredBy--&amp;gt;====&lt;br /&gt;
:--&lt;br /&gt;
==Technische specificaties in HL7v3 CDA en HL7 FHIR&amp;lt;!--ftHeader--&amp;gt;==&lt;br /&gt;
Om informatie op basis van zorginformatiebouwstenen uit te wisselen zijn aanvullende, meer technische specificaties nodig.&amp;lt;BR&amp;gt;Niet iedere omgeving kan met dezelfde technische specificaties overweg. Om deze reden zijn er meerdere typen technische specificaties:&amp;lt;!--ftReferenceIntro--&amp;gt;&lt;br /&gt;
&amp;lt;ul&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;HL7® versie 3 CDA compatibele specificaties, beschikbaar via de Nictiz ART-DECOR® omgeving&amp;lt;!--ftArtDecorReference--&amp;gt; {{ArtDecorLinks|2026-1|7.4}}&amp;lt;/li&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;HL7® FHIR® compatibele specificaties, beschikbaar via de Nictiz-omgeving op de Simplifier FHIR Registry&amp;lt;!--ftSimplifierReference--&amp;gt; {{SimplefierLinks|2026-1|DrugUse}}&amp;lt;/li&amp;gt;&lt;br /&gt;
&amp;lt;/ul&amp;gt;&lt;br /&gt;
==Downloads&amp;lt;!--ftDownloadTitle--&amp;gt;==&lt;br /&gt;
De bouwsteen is ook beschikbaar als [[Media:nl.zorg.DrugsGebruik-v3.5(2026-1NL).pdf|pdf bestand]] [[File:PDF.png|link=]] of als [[Media:nl.zorg.DrugsGebruik-v3.5(2026-1NL).xlsx|spreadsheet]] [[File:xlsx.png|link=]]&amp;lt;!--ftDownloads--&amp;gt;&lt;br /&gt;
==Over deze informatie&amp;lt;!--ftHeader2--&amp;gt;==&lt;br /&gt;
De informatie in deze wiki pagina is gebaseerd op de&amp;lt;!--ftInfoBase--&amp;gt; prepublicatie 2026-1 &amp;lt;BR&amp;gt;&lt;br /&gt;
SNOMED CT en LOINC codes zijn gebaseeerd op:&lt;br /&gt;
&amp;lt;ul&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;SNOMED Clinical Terms versie: 20260331 [R] (maart 2026-editie)&amp;lt;/li&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;LOINC version 2.81&amp;lt;/li&amp;gt;&lt;br /&gt;
&amp;lt;/ul&amp;gt;&lt;br /&gt;
De voorwaarden van gebruik staan op de beginpagina&amp;lt;!--ftConditions--&amp;gt; [[Bestand:list2.png|link=ZIB_Hoofdpagina&amp;lt;!--wikiMainpage--&amp;gt;]]&amp;lt;BR&amp;gt;&lt;br /&gt;
Deze pagina is gegenereerd op 17/04/2026 11:22:42 met ZibExtraction v. 10.0.9603.19166&amp;lt;!--ftDate--&amp;gt; &amp;lt;BR&amp;gt;&lt;br /&gt;
-----&lt;br /&gt;
&amp;lt;div style=&amp;quot;text-align: right; direction: ltr; margin-left: 1em;&amp;quot; &amp;gt;[[Bestand: Back 16.png| link= ZIB_Publicatie&amp;lt;!--wikiReleasePage--&amp;gt;_2026-1(NL)]] [[ZIB_Publicatie&amp;lt;!--wikiReleasePage--&amp;gt;_2026-1(NL) |Terug naar ZIB overzicht&amp;lt;!--hdBackToMainPage--&amp;gt; ]]&amp;lt;/div&amp;gt;&lt;/div&gt;</summary>
		<author><name>Update bot</name></author>
	</entry>
</feed>